Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01223716 · ClinicalTrials.gov registry record · NA
An Active Approach to Treat Amblyopia: Video Game Play
A NA study, sponsored by University of California, Berkeley.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01223716 is a NA study that has completed, run by University of California, Berkeley. The registered enrollment target is 20 participants.
The verdict
NCT01223716, a NA study, has completed, sponsored by University of California, Berkeley.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Amblyopia, a developmental abnormality that impairs spatial vision, is a major cause of vision loss, resulting in reduced visual acuity and reduced sensitivity to contrast. This study uses psychophysical measures to study neural plasticity in adults with amblyopia.
Interventions
- BEHAVIORAL Perceptual learning
- BEHAVIORAL Video Game
- BEHAVIORAL Crossover (Occlusion therapy + Video Game)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01223716
The ClinicalTrials.gov registry entry for NCT01223716 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Perceptual learning is the first listed.
NCT01223716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01223716 about?
NCT01223716 is a clinical study titled "An Active Approach to Treat Amblyopia: Video Game Play". Amblyopia, a developmental abnormality that impairs spatial vision, is a major cause of vision loss, resulting in reduced visual acuity and reduced sensitivity to contrast. This study uses psychophysical measures to study neural plasticity in adults with amblyopia.
What is the current status of trial NCT01223716?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2004-12. Estimated completion is 2009-12.
What interventions are being tested in trial NCT01223716?
The interventions under investigation include: Perceptual learning (BEHAVIORAL), Video Game (BEHAVIORAL), Crossover (Occlusion therapy + Video Game) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01223716?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.